BioSpace News Archive

Drug Development

Receptos Doses First Patient in Phase 2/3 Trial for RPC1063 in Multiple Sclerosis

October 22, 2012
·
4 min read
Business

Ligand Pharmaceuticals Inc. to Report Third Quarter Results on November 5th

October 22, 2012
·
1 min read
Probe Scientific’s Microeye® Technology Selected for Euros 5.2 Million EU In-Vivo Biomarker Monitoring Project

October 22, 2012
·
2 min read
Genetown

GI Dynamics Announces First Clinical Study to Demonstrate Improvement in Weight Loss and Co-morbid Conditions Following EndoBarrier Re-implantation

October 22, 2012
·
1 min read
Drug Development

VentiRx Pharmaceuticals, Inc. Initiates Randomized, Placebo-Controlled, Phase 2 Trial of VTX-2337 in Patients With Recurrent or Persistent Ovarian Cancer

October 22, 2012
·
3 min read
Drug Development

Janssen Research & Development Release: New One-Year Phase 3 Study Results Show Anti-TNF SIMPONI® Maintained Clinical Response in Treatment of Moderately to Severely Active Ulcerative Colitis

October 22, 2012
·
14 min read
BioMidwest

3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences

October 22, 2012
·
1 min read
Genetown

GI Dynamics Announces New Insights into EndoBarrier Therapy’s Influence on Key Hormones Affecting Satiety and Blood Sugar Control

October 22, 2012
·
1 min read
Genetown

IntelligentMDx to Present Development and Performance Data of 4 Infectious Disease Diagnostic Tests at AMP 2012 Annual Meeting

October 22, 2012
·
2 min read
Bio NC

Clinverse CEO Tim Immel and Medidata Solutions, Inc. Co-Host Technology Showcase at MAGI West Clinical Research Conference

October 22, 2012
·
1 min read